Skip to main content
Tuoxin Pharmaceutical Group Co.,Ltd. logo

Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 301089 ISIN · CNE100004YC3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2026-03-27 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 301089

About Tuoxin Pharmaceutical Group Co.,Ltd.

https://www.tuoxinpharm.com

Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.

Recent filings

Filing Released Lang Actions
营业收入扣除情况的专项说明
Audit Report / Information Classification · 85% confidence The document is a “专项说明” (special explanatory statement) prepared and certified by ShineWing certified public accountants, detailing the 2025 revenue deduction schedule and attesting its consistency with the audited financial statements (audit report issued March 27, 2026). This is a standalone audit disclosure (supplementary audit information), not the full annual report or mere announcement. It falls under Audit Report / Information. FY 2025
2026-03-27 Chinese
中天国富证券有限公司关于拓新药业集团股份有限公司2025年度募集资金存放与使用情况的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from a securities company acting as a sponsor, providing an audit and verification opinion on the use and storage of funds raised by a company (拓新药业集团股份有限公司) in the year 2025. It includes specifics on the amount raised, usage, balance, changes in project implementation, and compliance with regulatory rules. The document references regulatory approvals, detailed financial figures, project progress, and compliance with fundraising regulations. It is not a brief announcement or a certification letter but a comprehensive report on fundraising usage and compliance. This matches the definition of an Audit Report / Information (AR), which includes audit reports and results of regulatory checks on financial matters related to fundraising, excluding full annual reports. Therefore, the document should be classified as AR with high confidence. FY 2025
2026-03-27 Chinese
独立董事2025年度述职报告（杨德杰）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2025 Annual Work Report" for a company, detailing the independent director's attendance at meetings, participation in committees, and duties performed during the year 2025. It is a narrative report on the director's activities and responsibilities rather than a financial report or announcement. It does not contain financial statements or data, nor is it an announcement of voting results or management changes. This type of document fits best under Board/Management Information (MANG), as it relates to the activities and reports of a board member (independent director). The document length is short (1728 characters), and it is a direct report, not an announcement of a report publication or certification. Therefore, the classification is MANG with high confidence.
2026-03-27 Chinese
关于变更高级管理人员、拟变更董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement from a company about changes in its senior management and board of directors. It details the resignation of a director and vice president, the appointment of new directors and senior management, and includes their resumes. There is no financial data or report content, but rather a formal disclosure of personnel changes. This fits the definition of 'Board/Management Information' (MANG). The document length is short and focused solely on management changes, confirming it is not an annual report or other financial filing.
2026-03-27 Chinese
关于2025年度会计师事务所履职情况的评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm (信永中和会计师事务所) for the 2025 fiscal year audit engagement. It discusses the auditor's qualifications, audit scope, independence, and communication with management, as well as the company's assessment of the auditor's performance. It does not contain actual financial statements or detailed financial data but rather an assessment of the auditor's work and compliance with auditing standards. This type of document is a standalone audit-related report focusing on the auditor's performance and compliance, which fits the definition of an Audit Report / Information (AR). The document length is short (1479 characters), but it is not merely an announcement or publication notice; it contains substantive content about the audit firm's evaluation. Therefore, the correct classification is AR with high confidence. FY 2025
2026-03-27 Chinese
董事会审计委员会对会计师事务所2025年度履行监督职责情况的报告
Audit Report / Information Classification · 95% confidence The document is a report from the Board Audit Committee regarding the performance and supervision of the accounting firm for the fiscal year 2025. It details the audit firm's qualifications, audit procedures, communication with management, and overall evaluation of the audit work for the 2025 annual report. The document is not the annual report itself but a standalone audit-related report focusing on the audit firm's oversight and performance. It does not contain the full financial statements or comprehensive company activity but rather the audit committee's assessment and supervision report. This fits the definition of an Audit Report / Information (AR). The document length is 2520 characters, which is relatively short but contains substantive audit-related content, not just an announcement or certification. Therefore, the classification is AR with high confidence. FY 2025
2026-03-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.